Enhancing myeloablative fludarabine-busulfan conditioning with total marrow irradiation in high-risk myeloid disease
Year: 2025
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Fernando Molina, Alberto Mussetti, Anna Sureda
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Funders: Amgen, Sanofi, Gilead Sciences, Celgene
OpenAlex ID: W4414488902
FWCI:
Cites:
Cited by:
Related to:
